Mary R. Dusing

709 total citations
24 papers, 643 citations indexed

About

Mary R. Dusing is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Mary R. Dusing has authored 24 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Genetics and 7 papers in Surgery. Recurrent topics in Mary R. Dusing's work include Pancreatic function and diabetes (6 papers), Digestive system and related health (5 papers) and RNA and protein synthesis mechanisms (5 papers). Mary R. Dusing is often cited by papers focused on Pancreatic function and diabetes (6 papers), Digestive system and related health (5 papers) and RNA and protein synthesis mechanisms (5 papers). Mary R. Dusing collaborates with scholars based in United States and Australia. Mary R. Dusing's co-authors include Dan A. Wiginton, John J. Hutton, Bruce J. Aronow, S. Steven Potter, Jeffrey L. Stock, Karen L. Yager, David L. Lattier, J. Christopher States, Ann L. Akeson and David P. Witte and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Mary R. Dusing

24 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary R. Dusing United States 15 388 258 110 103 71 24 643
Marco L. Breuer Netherlands 10 296 0.8× 101 0.4× 90 0.8× 72 0.7× 132 1.9× 13 512
Nicole Malet France 13 275 0.7× 81 0.3× 105 1.0× 74 0.7× 71 1.0× 17 507
Nausheen J. Shervani Japan 10 204 0.5× 166 0.6× 48 0.4× 312 3.0× 122 1.7× 11 548
Ward Coats United States 6 540 1.4× 294 1.1× 103 0.9× 280 2.7× 145 2.0× 6 879
Hiroki Hirai Japan 15 328 0.8× 149 0.6× 111 1.0× 149 1.4× 79 1.1× 43 663
Stefanie Tippmer Germany 9 271 0.7× 65 0.3× 141 1.3× 90 0.9× 166 2.3× 12 648
Maki Igarashi Japan 14 705 1.8× 296 1.1× 47 0.4× 59 0.6× 77 1.1× 42 905
Thomas E. Akie United States 12 853 2.2× 141 0.5× 133 1.2× 34 0.3× 58 0.8× 17 1.3k
Kenzo Kaneko Japan 14 441 1.1× 64 0.2× 127 1.2× 178 1.7× 288 4.1× 37 838
Janna Nousbeck Israel 13 343 0.9× 143 0.6× 181 1.6× 52 0.5× 49 0.7× 20 700

Countries citing papers authored by Mary R. Dusing

Since Specialization
Citations

This map shows the geographic impact of Mary R. Dusing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary R. Dusing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary R. Dusing more than expected).

Fields of papers citing papers by Mary R. Dusing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary R. Dusing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary R. Dusing. The network helps show where Mary R. Dusing may publish in the future.

Co-authorship network of co-authors of Mary R. Dusing

This figure shows the co-authorship network connecting the top 25 collaborators of Mary R. Dusing. A scholar is included among the top collaborators of Mary R. Dusing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary R. Dusing. Mary R. Dusing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dusing, Mary R., et al.. (2024). Transient Seizure Clusters and Epileptiform Activity Following Widespread Bilateral Hippocampal Interneuron Ablation. eNeuro. 11(4). ENEURO.0317–23.2024. 1 indexed citations
2.
Dusing, Mary R., et al.. (2023). Neurovascular Development inPtenandTsc2Mouse Mutants. eNeuro. 10(2). ENEURO.0340–22.2023. 7 indexed citations
3.
Crawford, Kelly, et al.. (2015). Murine colitis treated with multitargeted tyrosine kinase inhibitors. Journal of Surgical Research. 200(2). 501–507. 4 indexed citations
4.
Crawford, Kelly, et al.. (2015). Angiogenesis and Vascular Endothelial Growth Factor-A Expression Associated with Inflammation in Pediatric Crohn’s Disease. Journal of Gastrointestinal Surgery. 20(3). 624–630. 19 indexed citations
5.
Crawford, Kelly, et al.. (2014). Mouse strain influences angiogenic response to dextran sodium sulfate–induced colitis. Journal of Surgical Research. 190(1). 47–54. 7 indexed citations
6.
Crawford, Kelly, et al.. (2013). Vascular endothelial growth factor receptor-2 inhibition in experimental murine colitis. Journal of Surgical Research. 184(1). 101–107. 11 indexed citations
7.
Dusing, Mary R., Elizabeth A. Maier, Bruce J. Aronow, & Dan A. Wiginton. (2010). Onecut-2 knockout mice fail to thrive during early postnatal period and have altered patterns of gene expression in small intestine. Physiological Genomics. 42(1). 115–125. 21 indexed citations
8.
Maier, Elizabeth A., Mary R. Dusing, & Dan A. Wiginton. (2006). Temporal Regulation of Enhancer Function in Intestinal Epithelium. Journal of Biological Chemistry. 281(43). 32263–32271. 7 indexed citations
9.
Dusing, Mary R. & Dan A. Wiginton. (2005). Epithelial lineages of the small intestine have unique patterns of GATA expression. The Histochemical Journal. 36(1-2). 15–24. 25 indexed citations
10.
Maier, Elizabeth A., Mary R. Dusing, & Dan A. Wiginton. (2005). Cdx Binding Determines the Timing of Enhancer Activation in Postnatal Duodenum. Journal of Biological Chemistry. 280(13). 13195–13202. 6 indexed citations
11.
Dusing, Mary R., et al.. (2003). High-level activation by a duodenum-specific enhancer requires functional GATA binding sites. American Journal of Physiology-Gastrointestinal and Liver Physiology. 284(6). G1053–G1065. 24 indexed citations
12.
Dusing, Mary R., et al.. (2001). PDX-1 Is Required for Activation in Vivo from a Duodenum-specific Enhancer. Journal of Biological Chemistry. 276(17). 14434–14442. 20 indexed citations
13.
Dusing, Mary R., et al.. (2000). A duodenum-specific enhancer regulates expression along three axes in the small intestine. American Journal of Physiology-Gastrointestinal and Liver Physiology. 279(5). G1080–G1093. 13 indexed citations
14.
Dusing, Mary R., Anthony G. Brickner, Mary Beth Thomas, & Dan A. Wiginton. (1997). Regulation of Duodenal Specific Expression of the Human Adenosine Deaminase Gene. Journal of Biological Chemistry. 272(42). 26634–26642. 19 indexed citations
15.
Haynes, Tracy, Mary Beth Thomas, Mary R. Dusing, et al.. (1996). An Enhancer LEF-1/TCF-1 Site is Essential for Insertion Site-Independent Transgene Expression in Thymus. Nucleic Acids Research. 24(24). 5034–5044. 18 indexed citations
16.
Brickner, Anthony G., David Gossage, Mary R. Dusing, & Dan A. Wiginton. (1995). Identification of a murine homolog of the human adenosine deaminase thymic enhancer. Gene. 167(1-2). 261–266. 14 indexed citations
17.
Dusing, Mary R. & Dan A. Wiginton. (1994). Sp1 is essential for both enhancer-mediated and basal activation of the TATA-less human adenosine deaminase promoter. Nucleic Acids Research. 22(4). 669–677. 54 indexed citations
18.
Sprecher, Dennis L., D Black, L. Kaplan, et al.. (1991). Chylomicron-retinyl palmitate clearance in type I hyperlipidemic families.. Journal of Clinical Investigation. 88(3). 985–994. 47 indexed citations
19.
Aronow, Bruce J., David L. Lattier, Mary R. Dusing, et al.. (1989). Evidence for a complex regulatory array in the first intron of the human adenosine deaminase gene.. Genes & Development. 3(9). 1384–1400. 116 indexed citations
20.
Akeson, Ann L., Dan A. Wiginton, Mary R. Dusing, J. Christopher States, & John J. Hutton. (1988). Mutant human adenosine deaminase alleles and their expression by transfection into fibroblasts.. Journal of Biological Chemistry. 263(31). 16291–16296. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marco L. Breuer Breakdown of academic impact, for papers by Nicole Malet Breakdown of academic impact, for papers by Nausheen J. Shervani Breakdown of academic impact, for papers by Ward Coats Breakdown of academic impact, for papers by Hiroki Hirai Breakdown of academic impact, for papers by Stefanie Tippmer Breakdown of academic impact, for papers by Maki Igarashi Breakdown of academic impact, for papers by Thomas E. Akie Breakdown of academic impact, for papers by Kenzo Kaneko Breakdown of academic impact, for papers by Janna Nousbeck
Rankless by CCL
2026